Skip to content

13F-HR filed by Exome Asset Management LLC

Exome Asset Management LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 14:10:47 UTC, with 55 holding rows worth $153,028,952.

Accession
0001420506-26-002739
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 55 entries on the cover page, a total value of $153,028,952 stated on the cover page (in dollars after the unit check, H1), rows summing to $153,028,952 with VALUE read as dollars as filed, 13F file number 028-23951. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GUARDANT HEALTH INC COM40131M109Stock67,500$12,039,300dollars as filed
TG THERAPEUTICS INC COM88322Q108Stock187,671$10,468,288dollars as filed
ABIVAX SA-00370M103SPONSORED ADS90,919$9,002,799dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW29,681$8,643,998dollars as filed
COGENT BIOSCIENCES INC19240Q201COM210,523$6,740,946dollars as filed
Eli Lilly and Company532457108COM5,492$6,354,683dollars as filed
NATERA INC COM632307104Stock13,800$5,703,678dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK159,556$5,152,063dollars as filed
VIKING THERAPEUTICS INC92686J106COM147,497$4,808,402dollars as filed
IONIS PHARMACEUTICALS INC COM462222100Stock107,034$4,779,068dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock100,203$4,593,306dollars as filed
CARIS LIFE SCIENCES INC142152107COMMON STOCK146,093$4,474,829dollars as filed
NEKTAR THERAPEUTICS640268306COMMON STOCK73,708$4,462,651dollars as filed
CYTOKINETICS INC23282W605COM NEW60,056$3,958,291dollars as filed
VERASTEM INC92337C203COMMON STOCK429,041$3,453,780dollars as filed
MAZE THERAPEUTICS INC COM578784100Stock114,692$3,117,329dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM32,209$3,066,780dollars as filed
10X GENOMICS INC CL A COM88025U109Stock30,074$2,717,487dollars as filed
ALKERMES PLCG01767105SHS61,336$2,485,335dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock4,109$2,226,626dollars as filed
Boston Scientific Corporation101137107COM48,347$2,110,347dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM32,214$2,108,406dollars as filed
UnitedHealth Group Inc91324P102COM5,697$2,091,255dollars as filed
OCULAR THERAPEUTIX INC67576A100COM272,046$2,086,593dollars as filed
ALUMIS INC022307102COM282,253$2,085,850dollars as filed
PENUMBRA INC COM70975L107Stock6,300$2,005,542dollars as filed
Intuitive Surgical,Inc.46120E602COM4,908$1,995,740dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock166,493$1,947,968dollars as filed
COMPASS PATHWAYS PLC20451W101SPONSORED ADS153,087$1,904,402dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW56,269$1,823,678dollars as filed
Merck & Co.,Inc.58933Y105COM12,358$1,795,741dollars as filed
LIQUIDIA CORPORATION COM NEW53635D202Stock59,155$1,790,030dollars as filed
GLAUKOS CORP COM377322102Stock10,862$1,783,432dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM137,015$1,634,589dollars as filed
BRIDGEBIO PHARMA INC10806X102COM21,209$1,395,552dollars as filed
CLEARPOINT NEURO INC18507C103COM110,174$1,345,225dollars as filed
CORBUS PHARMACEUTICALS21833P301COM NEW190,714$1,300,669dollars as filed
CYTOMX THERAPEUTICS INC23284F105COMMON STOCK460,067$1,251,382dollars as filed
PALVELLA THERAPEUTICS INC697947109COMMON STOCK7,809$1,077,095dollars as filed
ASCENDIS PHARMA A/SK08588103ORD SHS *A*4,414$1,005,642dollars as filed
RAPPORT THERAPEUTICS INC COM75383L102Stock29,381$987,202dollars as filed
BILLIONTOONE INC090168105CL A8,983$956,151dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock34,341$926,177dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK68,488$906,781dollars as filed
EQUILLIUM INC29446K106COM552,956$898,554dollars as filed
ESTABLISHMENT LABS HOLDINGSG31249108COMMON STOCK13,100$840,627dollars as filed
CLIMB BIO INC28658R106COMMON STOCK71,215$816,836dollars as filed
NOVABRIDGE BIOSCIENCES44975P103CMN576,960$787,550dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK14,715$733,101dollars as filed
COMPASS THERAPEUTICS INC20454B104COM511,084$531,527dollars as filed
Q32 BIO INC746964105Common Stock62,589$517,611dollars as filed
CAPRICOR THERAPEUTICS INC14070B309COMMON STOCK51,531$487,999dollars as filed
UNIQURE NVN90064101SHS18,300$442,128dollars as filed
Arbutus Biopharma Corp03879J100Common Shares, without par value50,166$239,793dollars as filed
ADAGENE INC005329107CMN52,543$168,138dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-26-002739this filing2026-11-16